During the process of hemodialysis treatment, interactions occur between blood and artificial medical materials. For instance, the dialysis membrane of an artificial kidney, also known as a hemodialyzer, exhibits different degrees of biocompatibility with blood due to its chemical and physical properties upon contact. This makes the dialysis membrane of the hemodialyzer play a pivotal role. Poor overall design of the hemodialyzer and low biocompatibility of the dialysis membrane can lead to various issues in hemodialysis patients. These issues may include white blood cell activation, complement activation, cytokine activation, platelet activation leading to coagulation cascade initiation, and various related issues, including chest tightness, low blood pressure during dialysis, and noticeable blood clotting in artificial kidneys, have been observed in clinical practice. Currently, dialysis membranes used in hemodialyzer are categorized as cellulose membranes, semi-synthetic membranes, and synthetic membranes. Among these, synthetic membranes offer superior biocompatibility, making them the first choice in clinical applications.